- TOLENTINO COLLADO J, Wang M, Li SX, Cifone MT, et al
Time-Dependent Activity of SARS-CoV-2 M(pro) Inhibitors.
Antiviral Res. 2026 Nov 20:106574. doi: 10.1016/j.antiviral.2026.106574.
PubMed Abstract available - BOLEY PA, Hartley G, Saif LJ, Bowman AS, et al
Zoonotic Exposure to Porcine Deltacoronavirus, United States, 2019-2021.
Emerg Infect Dis. 2026;32:2107-2109.
PubMed Abstract available - GOTERRIS L, Koster PC, Fuentes J, Sulleiro E, et al
Post-COVID-19 Emergence and Spread of Hypertransmissible Cryptosporidium hominis gp60 Subtype IfA12G1R5, Spain.
Emerg Infect Dis. 2026;32:2067-2071.
PubMed Abstract available - DING P, Yao Y, Li K, Huang Y, et al
Viral detection and clinical heterogeneity among severe community-acquired pneumonia patients stratified by respiratory virus status: a secondary analysis of combined retrospective and prospective multicenter cohorts.
Int J Infect Dis. 2026 Nov 19:109257. doi: 10.1016/j.ijid.2026.109257.
PubMed Abstract available - XIANG C, Yan M, Cao B, Wang Y, et al
Natural Killer Cell Decrease at Admission Is Associated With Severe Outcomes in Hospitalized Influenza and COVID-19: An 8-Year Retrospective Cohort Study.
Int J Infect Dis. 2026 Nov 18:109250. doi: 10.1016/j.ijid.2026.109250.
PubMed Abstract available - ISHIOKA H, Uchino S, Shiotsuka J
Temporal Changes in Body Mass Index among Patients with Severe COVID-19 in Japan.
Int J Infect Dis. 2026 Nov 14:109255. doi: 10.1016/j.ijid.2026.109255.
PubMed Abstract available - MUKHERJEE A, Anand T, Singh KJ, Sharma L, et al
Reinfection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2) among healthcare workers in India.
Int J Infect Dis. 2026 Nov 13:109249. doi: 10.1016/j.ijid.2026.109249.
PubMed Abstract available - MEMISH ZA, Sreffen R
Respiratory Infections at Mass Gatherings: A Travel-Medicine Review with Hajj and Umrah as a Longitudinal Case Study.
J Travel Med. 2026 Nov 14:taag105. doi: 10.1093.
PubMed Abstract available - YANG L, Luo M, Lu Y, Wang H, et al
Establishment and characterization of a recombinant VSV-based pseudotyping platform for studying RSV F-mediated entry and antibody-mediated neutralization.
J Virol. 2026 Nov 18:e0146626. doi: 10.1128/jvi.01466.
PubMed Abstract available - HARMAN MAJ, Gaynor KU, Papa G, Pellegrino S, et al
Investigation of anti-SARS-CoV-2 multimeric bicyclic peptide inhibitors in a range of preclinical therapeutic settings.
J Virol. 2026 Nov 18:e0122426. doi: 10.1128/jvi.01224.
PubMed Abstract available - GOHMANN L, Reid W, Tsai B
Primer: Virus entry and uncoating.
J Virol. 2026 Nov 18:e0165626. doi: 10.1128/jvi.01656.
PubMed Abstract available - RUBIN R
After COVID-19 Vaccination, Why Do Some People Run a Fever?
JAMA. 2026 Nov 13. doi: 10.1001/jama.2026.22638.
PubMed - KIMURA Y, Tanimura K, Inoue N, Herbrecht R, et al
Mortality and prognostic factors in invasive aspergillosis: a systematic review and individual patient data meta-analysis.
Lancet Infect Dis. 2026 Nov 19:S1473-3099(26)00525.
PubMed Abstract available - WINN AK, Anglin O, Anderson EL, Prill MM, et al
Respiratory Virus Activity - United States, July 2025-June 2026.
MMWR Morb Mortal Wkly Rep. 2026;75:662-668.
PubMed Abstract available - GRIPPIN AJ, Marconi C, Copling S, Li N, et al
Author Correction: SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade.
Nature. 2026 Nov 20. doi: 10.1038/s41586-026-10974.
PubMed - LEDFORD H
University students are biggest spreaders of COVID.
Nature. 2026 Nov 19. doi: 10.1038/d41586-026-03746.
PubMed
Antiviral Res

No comments:
Post a Comment